Tieto and BC Platforms bring genomics to precision medicine

Tieto and BC Platforms bring genomics to precision medicine. This new approach will transform healthcare providers’ clinical decision making by providing them a new platform for more accurate and faster diagnoses, and thereby contributing to even more personalized care.

As noted at e.g. the global Healthcare Information and Management Systems Society (HIMSS) 2018 summit, precision medicine is entering the mainstream clinical workflow by facilitating better predictive care. This paradigm shift is enabled by the scientific and technological advances in the field of genomics leading to time and cost no longer constituting a barrier for precision medicine.

Tieto, one of the largest healthcare IT providers in Northern Europe, together with BC Platforms, a world leader in genomic data management and analytics, partnered to bring the benefits of genomics into predictive medicine. A new platform which combines genomics data and clinical data, provides new means for improving the quality of the diagnostic process. Tieto and BC Platform will do joint solution development and marketing leveraging BC platforms niche expertise together with Tieto’s strong position as a leading IT solution, integrator and service provider for the Nordic Health professionals.

“Genomic medicine is making a large impact to clinical care quality in the fields of oncology, pharmacology, rare and undiagnosed diseases, and infectious diseases. Together with BC Platforms, we can empower our Lifecare solutions for Lab Information Management Systems (LIMS) and Electronic Medical Records (EMR) offerings to ensure that genomics data together with clinical data will be used to more accurately guide individual diagnoses and treatments, but also provide support of preventive and predictive medical decision making,” says Inge Andersson, Head of Product Portfolio and Offerings at  Healthcare, Welfare and Education Nordic at Tieto.

”Major Nordic Hospitals are very much at the forefront of deploying solutions to personalize their patients’ healthcare. The ability to process raw genome data in one platform to deliver actionable patient reports is a major advancement. Tieto is the largest healthcare specific system integrator in North Europe with a long history in healthcare, which makes them a great partner for us,” comments Brett Villagrand, Head of Marketing at BC Platforms. “BC Platforms wants to “democratize” the use of genomic data in both healthcare and Life Sciences. Partnerships like the one with Tieto will deliver on the promise of precision medicine.”

As AI adoption lags among UK SMEs, potential risks emerge. How can small businesses overcome...
BOXX Insurance is set to join Zurich Insurance Group, continuing its mission in cyber insurance and...
CISPE appeals Broadcom's VMware acquisition approval, citing competition risks and exclusion of...
runZero teams up with Aqaio to enhance its exposure management platform in Germany, aiming to...
A study reveals significant benefits and challenges for U.K. businesses transitioning to Microsoft...
Red Hat introduces updates to streamline partner interactions, focusing on specialisation and...
Slow AI adoption poses financial risks for UK businesses, but strategic opportunities exist in...
Tintri's VMstore is setting new standards in data management for Kubernetes, with significant...